Category: Approval/Launch Region: North America · United States Company: Caris Life Sciences Inc

Caris Life Hummingbird Bioscience ink collaboration to advance clinical development of anti-HER3 therapy HMBD-001

Caris Life Hummingbird Bioscience ink collaboration to advance clinical development of anti-HER3 therapy HMBD-001
Caris Life Sciences (Caris), the leading molecular science and technology company, and Hummingbird Bioscience, a data-driven precision biotherapeutics company, announced a strategic collaboration to advance clinical development of Hummingbird Bioscience

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!